Gilead SciencesNASDAQ: GILD: Develops and sells medicines for life-threatening infectious diseases.
8+ YOE8+ years in pharma or managed care with HEOR experience; expertise in HEOR study and model design, value dossiers, and US/global reimbursement; strong communication and analytical skills; advanced HEOR degree preferred.
AbbottNYSE: ABT: Provides medical devices, diagnostics, and science-based nutritional products.
7+ YOEAdvanced degree in HEOR/epidemiology preferred, 7+ years HEOR/evidence generation or reimbursement experience, knowledge of US market access, strong project management, presentation and stakeholder collaboration skills.
Adverum Biotechnologies: Developing gene therapies to treat and prevent vision loss.
10+ YOEAdvanced degree in health field, 7–10+ years HEOR/pharmaceutical experience, ophthalmology/retina experience required, global HTA familiarity, cross-functional leadership and evidence generation expertise.
Neurocrine BiosciencesNASDAQ: NBIX: Develops pharmaceuticals for neurological, endocrine, and psychiatric disorders.
4+ YOEAdvanced degree in HEOR/Health Economics (MPH/MS/PhD/PharmD) with 4+–6+ years pharma HEOR experience, prior managerial experience, strong data analysis and publication writing, SAS and MS Office proficiency.
Microsoft Word, Microsoft Excel, Microsoft PowerPoint, SAS
AbbVieNYSE: ABBV: Develops and sells innovative pharmaceutical and biopharmaceutical medicines.
7+ YOEAdvanced degree in health economics or related field, 7+ years' HEOR experience with Master's (5+ with PhD), pharmaceutical/clinical development experience, leadership in cross-functional teams, HTA/regulatory knowledge.
AbbottNYSE: ABT: Manufactures medical devices, diagnostics, and nutritional health products.
7+ YOEAdvanced degree (masters/PhD/MD) preferred in health economics, outcomes research or epidemiology; 7+ years HEOR/evidence generation/reimbursement experience; strong project management, communication, and commercial acumen.
Revolution MedicinesNASDAQ: RVMD: Developing precision oncology therapies for RAS-addicted cancers
12+ YOEDeep HEOR/RWE expertise in biotech/pharma, oncology experience, track record of publications, payer/HTA knowledge, strong communication and stakeholder engagement skills.
Gilead SciencesNASDAQ: GILD: Develops and sells medicines for life-threatening infectious diseases.
8+ YOE8+ years pharmaceutical/managed care experience in HEOR, expertise designing HEOR studies/models, understanding of global reimbursement, strong communication skills; advanced degree in HEOR preferred.
San Francisco or New York City or Chicago or United States
$213k-$288k/yrHybridFull Time
Komodo Health: Provides AI-driven healthcare data and patient journey analytics software.
10+ YOE10+ years of hands-on RWE/HEOR experience, expert market knowledge, strong analytical and communication skills, and comfort using AI tools to prototype and build product solutions.
Sr. Director, Global Head of Health Economics & Outcomes Research (Hybrid-Acton, MA or San Diego, CA)
Acton or San Diego or London or United States or United Kingdom or France or Germany or Netherlands or Canada or Mexico or Australia or United Arab Emirates or Europe
$221k-$332k/yrHybridFull Time
InsuletNasdaq: PODD: Manufactures wearable tubeless insulin pumps for diabetes care.
15+ YOE15+ MgmtBachelor’s degree required; 15+ years HEOR leadership experience in life sciences or consultancy; deep expertise in economic modeling, RWE, HTA, publication record, and building global HEOR teams.
AlumisNASDAQ: ALMS: Develops precision medicines for patients with autoimmune diseases.
5+ YOEAdvanced degree (PharmD, PhD, MD, MPH or equivalent), 5+ years in Medical Affairs/HEOR/Market Access, payer engagement experience, HEOR/RWE knowledge, strong communication and stakeholder engagement skills.
Travere TherapeuticsNASDAQ: TVTX: Developing and selling therapies for rare kidney diseases.
12+ YOE5+ MgmtBachelor's degree required; 12+ years relevant experience and 5+ years progressive leadership in market access/marketing/HEOR; deep payer, pricing, contracting, HEOR, and launch experience for specialty/rare products.
Trinity Life Sciences: Strategic consulting and analytics for life sciences companies.
3+ YOE3-4 years in top-tier biopharma strategy consulting; US healthcare pricing knowledge; degree in health sciences, economics, or HEOR; proficient in English and research/dataproc.
MS Office, Word, PowerPoint, Outlook, PubMed, Medline, Google Scholar
Mirum PharmaceuticalsNASDAQ: MIRM: Develops and commercializes therapies for rare liver diseases.
18+ YOE10+ MgmtBachelor's degree required; 18+ years progressive pharma/biotech leadership with ≥10 years leading market access; experience in pricing, contracting, payer strategy, HEOR, and cross-functional execution.
Senior Medical Science Outcomes Liaison - Northern California
California, United States
$175k-$216k/yrFieldFull Time
Akebia TherapeuticsNasdaq: AKBA: Developing innovative therapeutics for patients with kidney disease.
3+ YOEAdvanced clinical/scientific doctorate, 3+ years relevant experience, field-based MSL/MSOL or medical affairs background, ability to communicate HEOR/RWE and clinical evidence, travel up to 70%.
Kardigan: Developing precision medicines to treat and cure cardiovascular disease.
10+ YOEBachelor's required; 10+ years pharma/biotech experience with ≥6 years in market access or managed care; experience with product launch, payer strategy, HEOR, patient services, and team building; travel up to 30%.
Foster City or Santa Monica or Parsippany or Ventura or Thousand Oaks
$196k-$253k/yrOnsiteFull Time
Kite PharmaNASDAQ: GILD: Developing engineered cell therapies to treat and cure cancer.
2+ YOEBachelor's +10 yrs or Master's +8 yrs or PhD +2 yrs; experience in payer strategy, HEOR/evidence translation, and oncology/cell therapy preferred; advanced PowerPoint and Excel skills; people leadership experience.